Transgenic and Gene Replacement Models of Epilepsy: Targeting Ion Channel and Neurotransmission Pathways in Mice

Models of Seizures and Epilepsy

Volumn , Issue , 2006, Pages 199-222

  Burgess, Daniel L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34249795832     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088554-1/50018-9     Document Type: Chapter

References (99)

1. Accili D. A note of caution on the Knockout Mouse Project. Nat Genet 2004, 36:1132.
2. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R., Ji F.Y., Kanbara N., et al. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 1996, 229:891-895.
3. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A., et al. Gene ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29.
4. Austin C.P., Battey J.F., Bradley A., Bucan M., Capecchi M., Collins E.S., Dove W.F., et al. The knockout mouse project. Nat Genet 2004, 36:921-924.
5. Auwerx J., Avner P., Baldock R., Ballabio A., Balling R., Barbacid M., Berns A., et al. The European dimension for the mouse genome mutagenesis program. Nat Genet 2004, 36:925-927.
6. 1A subunit of P/Q type calcium channels. Neuroscience 2000, 95:639-645.
7. Backman C.M., Zhang Y., Hoffer B.J., Tomac A.C. Tetracycline-inducible expression systems for the generation of transgenic animals: a comparison of various inducible systems carried in a single vector. J Neurosci Methods 2004, 139:257-262.
8. A receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nat Genet 2001, 28:46-48.
9. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406.
10. Bode J., Goetze S., Heng H., Krawetz S.A., Benham C. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chrom Res 2003, 11:435-445.
11. - channel disruption. EMBO J 2001, 20:1289-1299.
12. Browne D.L., Gancher S.T., Nutt J.G., Brunt E.R., Smith E.A., Kramer P., Litt M. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene KCNA1. Nat Genet 1994, 8:136-140.
13. Brusa R., Zimmermann F., Koh D.S., Feldmeyer D., Gass P., Seeburg P.H., Sprengel R. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
14. 2+ channel subunit compositions in lethargic mouse brain. Mol Cell Neurosci 1999, 13:293-311.
15. 3 (R192H). Hum Genet 2002, 111:154-160.
16. Capecchi M.R. The new mouse genetics: altering the genome by gene targeting. Trends Genet 1989, 5:70-76.
17. Capecchi M.R. Altering the genome by homologous recombination. Science 1989, 244:1288-1292.
18. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 1998, 18:53-55.
19. 1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 2004, 24:4030-4042.
20. 2-subunits. Proc Natl Acad Sci U S A 2002, 99:17072-17077.
21. Cogoni C., Macino G. Post-transcriptional gene silencing across kingdoms. Genes Dev 2000, 10:638-643.
22. Cossette P., Liu L., Brisebois K., Dong H., Lortie A., Vanasse M., Saint-Hilaire J.M., et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002, 31:184-189.
23. Donahue L.R., Cook S.A., Johnson K.R., Bronson R.T., Davisson M.T. Megencephaly: a new mouse mutation on chromosome 6 that causes hypertrophy of the brain. Mamm Genome 1996, 7:871-876.
24. Dooley J.M., Berg J.M., Pakula Z., MacGregor D.L. The puppet-like syndrome of Angelman. Am J Dis Child 1981, 135:621-624.
25. Dykxhoorn D.M., Novina C.D., Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003, 4:457-467.
26. Eunson L.H., Rea R., Zuberi S.M., Youroukos S., Panayiotopoulos C.P., Liguori R., Avoni P., et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000, 48:647-656.
27. Fletcher C.F., Lutz C.M., O'Sullivan T.N., Shaughnessy J.D., Hawkes R., Frankel W.N., Copeland N.G., et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996, 87:607-617.
28. Gardner R.L., Brook F.A. Reflections on the biology of embryonic stem (ES) cells. Int J Dev Biol 1997, 41:235-243.
29. Giraldo P., Montoliu L. Size matters: use of YACs, BACs and PACs in transgenic animals. Transgenic Res 2001, 10:83-103.
30. Gong S., Zheng C., Doughty M.L., Losos K., Didkovsky N., Schambra U.B., Nowak N.J., et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 2003, 425:917-925.
31. Gordon J.W., Scangos G.A., Plotkin D.J., Barbosa J.A., Ruddle F.H. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci U S A 1980, 77:7380-7384.
32. Gunther U., Benson J., Benke D., Fritschy J.M., Reyes G., Knoflach F., Crestani F., et al. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 1995, 92:7749-7753.
33. Hasuwa H., Kaseda K., Einarsdottir T., Okabe M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 2002, 532:227-230.
34. Haug K., Warnstedt M., Alekov A.K., Sander T., Ramirez A., Poser B., Maljevic S., et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003, 33:527-532.
35. Heintz N. Analysis of mammalian central nervous system gene expression and function using bacterial artificial chromosome-mediated transgenesis. Hum Mol Genet 2000, 9:937-943.
36. Heron S.E., Crossland K.M., Andermann E., Phillips H.A., Hall A.J., Bleasel A., Shevell M., et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 2002, 360:851-852.
37. Hofker M.H., Deursen J.V. Transgenic Mouse: Methods and Portocols 2002, Humana Press, Totowa.
38. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 1991, 252:851-853.
39. 3 subunit have epilepsy, cleft palate, and hypersensitive behavior. Proc Natl Acad Sci U S A 1997, 94:4143-4148.
40. Houdebine L.M. Animal Transgenesis and Cloning 2003, John Wiley & Sons, Hoboken.
41. Huber L.A. Is proteomics heading in the wrong direction?. Nat Rev Mol Cell Biol 2003, 4:74-80.
42. Imbrici P., Jaffe S.L., Eunson L.H., Davies N.P., Herd C., Robertson R., Kullmann D.M., et al. Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 2004, 127:2682-2692.
43. Ivics Z., Izsvak Z. Transposable elements for transgenesis and insertional mutagenesis in vertebrates: a contemporary review of experimental strategies. Methods Mol Biol 2004, 260:255-276.
44. Jackson I.J., Abbott C.M. Mouse Genetics and Transgenics: A Practical Approach 2000, Oxford University Press, Oxford.
45. Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R., Taverna F.A., et al. Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 1996, 17:945-956.
46. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., Hanna M.G. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001, 358:801-807.
47. Joyner A.J. Gene Targeting: A Practical Approach 2000, Oxford University Press, Oxford.
48. + channel gene modifies the electrical properties and synaptic efficacy of identified Aplysia neurons. Proc Natl Acad Sci U S A 1992, 89:1133-1137.
49. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci U S A 1997, 94:14060-14065.
50. Kask K., Zamanillo D., Rozov A., Burnashev N., Sprengel R., Seeburg P.H. The AMPA receptor subunit GluR-B in its Q/R site-unedited form is not essential for brain development and function. Proc Natl Acad Sci U S A 1998, 95:13777-13782.
51. Kearney J.A., Plummer N.W., Smith M.R., Kapur J., Cummins T.R., Waxman S.G., Goldin A.L., Meisler M.H. A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001, 102:307-317.
52. 2+ channels. Neuron 2001, 31:35-45.
53. Kunath T., Gish G., Lickert H., Jones N., Pawson T., Rossant J. Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. Nat Biotechnol 2003, 21:559-561.
54. Kuwabara T., Hsieh J., Nakashima K., Taira K., Gage F.H. A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 2004, 116:779-793.
55. Liu M., Pleasure S.J., Collins A.E., Noebels J.L., Naya F.J., Tsai M.J., Lowenstein D.H. Loss of BETA2/NeuroD leads to malformation of the dentate gyrus and epilepsy. Proc Natl Acad Sci U S A 2000, 97:865-870.
56. Marcus K., Schmidt O., Schaefer H., Hamacher M., van Hall A., Meyer H.E. Proteomics-application to the brain. Int Rev Neurobiol 2004, 61:285-311.
57. McKnight R.A., Shamay A., Sankaran L., Wall R.J., Hennighausen L. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A 1992, 89:6943-6947.
58. Meisler M.H. Insertional mutation of 'classical' and novel genes in transgenic mice. Trends Genet 1992, 8:341-344.
59. Nagy A., Gertsenstein M., Vintersten K., Behringer R. Manipulating the Mouse Embryo: A Laboratory Manual 2002, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
60. Naya F.J., Huang H.P., Qiu Y., Mutoh H., DeMayo F.J., Leiter A.B., Tsai M.J. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 1997, 11:2323-2334.
61. Novina C.D., Sharp P.A. The RNAi revolution. Nature 2004, 430:161-164.
62. Nuyens D., Stengl M., Dugarmaa S., Rossenbacker T., Compernolle V., Rudy Y., Smits J.F., et al. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nature Med 2001, 7:1021-1027.
63. 2+ channel gene CACNL1A4. Cell 1996, 87:543-552.
64. Pereira S., Vieira J.P., Barroca F., Roll P., Carvalhas R., Cau P., Sequeira S., et al. Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. Neurology 2004, 63:191-192.
65. Peters H.C., Hu H., Pongs O., Storm J.F., Isbrandt D. Conditional transgenic suppression of M-channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat Neurosci 2005, 8:51-60.
66. Petersson S., Persson A.S., Johansen J.E., Ingvar M., Nilsson J., Klement G., Arhem P., et al. Truncation of the Shaker-like voltage-gated potassium channel, Kv1.1., causes megencephaly. Eur J Neurosci 2003, 18:3231-3240.
67. Pinkert C. Transgenic Animal Technology: A Laboratory Handbook 2002, Academic Press, San Diego.
68. Planells-Cases R., Caprini M., Zhang J., Rockenstein E.M., Rivera R.R., Murre C., Masliah E., et al. Neuronal death and perinatal lethality in voltage-gated sodium channel alpha-II deficient mice. Biophys J 2000, 78:2878-2891.
69. Prawitt D., Brixel L., Spangenberg C., Eshkind L., Heck R., Oesch F., Zabel B., et al. RNAi knock-down mice: an emerging technology for post-genomic functional genetics. Cytogenet Genome Res 2004, 105:412-421.
70. B1-deficient mice. Mol Cell Neurosci 2001, 17:1059-1070.
71. Sans N., Vissel B., Petralia R.S., Wang Y.X., Chang K., Royle G.A., Wang C.Y., et al. Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit. J Neurosci 2003, 23:9367-9373.
72. Schoonjans L., Kreemers V., Danloy S., Moreadith R.W., Laroche Y., Collen D. Improved generation of germline-competent embryonic stem cell lines from inbred mouse strains. Stem Cells 2003, 21:90-97.
73. B1. Neuron 2001, 31:47-58.
74. A receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci 2003, 24:442-450.
75. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998, 18:25-29.
76. V1.1 potassium channel causes epilepsy in mice. Neuron 1998, 20:809-819.
77. Su A.I., Cooke M.P., Ching K.A., Hakak Y., Walker J.R., Wiltshire T., Orth A.P., et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 2002, 99:4465-4470.
78. v1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci U S A 2001, 98:6384-6389.
79. A receptor subtype in the brain is not lethal in mice. J Neuroscience 2001, 21:3409-3418.
80. Surani M.A. Influence of genome imprinting on gene expression, phenotypic variations and development. Hum Reprod 1991, 6:45-51.
81. + channel in mammalian central nervous system dysregulates native potassium channel gene expression. Proc Natl Acad Sci U S A 1999, 96:2451-2455.
82. Testa G., Vintersten K., Zhang Y., Benes V., Muyrers J.P., Stewart A.F. BAC engineering for the generation of ES cell-targeting constructs and mouse transgenes. Methods Mol Biol 2004, 256:123-139.
83. Turksen K. Embryonic Stem Cells: Methods and Protocols 2001, Humana Press, Totowa.
84. Tymms M.J., Kola I. Gene Knockout Protocols 2001, Humana Press, Totowa.
85. Veenema H., Beverstock G.C., Zvelebil-Tarasevitch N., Doorn J.L., van Parys J.A., Kamp J.J. Duplication in the proximal portion of the long arm of chromosome 15, in a girl without phenotypic features of the Prader-Willi syndrome. Clin Genet 1984, 26:65-68.
86. 1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J Neurosci 2001, 21:3009-3016.
87. 3 subunit to the Angelman/Prader-Willi region of human chromosome 15. Am J Hum Genet 1991, 49:330-337.
88. 2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 2001, 28:49-52.
89. 1 subunit gene SCN1B. Nat Genet 1998, 19:366-370.
90. Walz K., Caratini-Rivera S., Bi W., Fonseca P., Mansouri D.L., Lynch J., Vogel H., et al. Modeling del(17)(p11. 2p11. 2) and dup(17)(p11. 2p11. 2) contiguous gene syndromes by chromosome engineering in mice: phenotypic consequences of gene dosage imbalance. Mol Cell Biol 2003, 23:3646-3655.
91. Watanabe H., Nagata E., Kosakai A., Nakamura M., Yokoyama M., Tanaka K., Sasai H. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. J Neurochem 2000, 75:28-33.
92. Williams S.N., Locke C.J., Braden A.L., Caldwell K.A., Caldwell G.A. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum Mol Genet 2004, 13:2043-2059.
93. Wu X., Burgess S.M. Integration target site selection for retroviruses and transposable elements. Cell Mol Life Sci 2004, 61:2588-2596.
94. Xia H., Mao Q., Eliason S.L., Harper S.Q., Martins I.H., Orr H.T., Paulson H.L., et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004, 10:816-820.
95. Yamamoto A., Hen R., Dauer W.T. The ons and offs of inducible transgenic technology: a review. Neurobiol Dis 2001, 8:923-932.
96. Yamamoto T., Yamato E., Tashiro F., Sato T., Noso S., Ikegami H., Tamura S., et al. Development of autoimmune diabetes in glutamic acid decarboxylase 65 ( GAD65) knockout NOD mice. Diabetologia 2004, 47:221-224.
97. Zhang H., Tan J., Reynolds E., Kuebler D., Faulhaber S., Tanouye M. The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure. Genetics 2002, 162:1283-1299.
98. Zhang W., Morris Q.D., Chang R., Shai O., Bakowski M.A., Mitsakakis N., Mohammad N., et al. The functional landscape of mouse gene expression. J Biol 2004, 3:21.
99. Zhuchenko O., Bailey J., Bonnen P., Ashizawa T., Stockton D.W., Amos C., Dobyns W.B., et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997, 15:62-69.